Stacey L. Amorosi
Boston Scientific (United States)(US)Takeda (United States)(US)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Peripheral Artery Disease Management, Coronary Interventions and Diagnostics
Most-Cited Works
- → Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database(2008)132 cited
- → Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF(2015)96 cited
- → Cost analysis of “bridging therapy” with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation(2004)53 cited
- → Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin(2016)51 cited
- → Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data(2019)45 cited
- → Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation(2018)44 cited